Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps.

BACKGROUND Measurements of aldosterone have become more common since the recognition that primary aldosteronism is a more frequent cause of hypertension than previously believed. Our aim was to compare concentrations reported by 4 assays for samples obtained after saline infusion during dynamic testing. METHODS We tested 104 participants (27 with primary aldosteronism, 30 with essential hypertension, and 47 healthy controls) with the intravenous saline infusion test (2.0 L isotonic saline over 4 h), with repetitive sampling. In all blood samples, aldosterone concentration was measured by an in-house RIA after extraction and chromatography, by 2 commercially available RIAs without extraction (Aldosterone Maia, Adaltis; Active Aldosterone, Diagnostics Systems Laboratories) and by an automated CLIA (Advantage, Nichols Institute Diagnostics). RESULTS Correlation coefficients for results of pairs of assays ranged from 0.74 to 0.98. Agreement between commercial assays and in-house RIA was best at the low to intermediate concentrations after saline infusion. Mean (SD) Adaltis and DSL RIA results were 2- to 3-times higher [healthy participants: 78 (25) ng/L and 56 (18) ng/L, respectively] than those obtained by Nichols CLIA [17 (8) ng/L] and in-house RIA [23 (18) ng/L]. Aldosterone concentrations measured by the Nichols CLIA were below the limit of detection (limit of the blank) in 27 of 47 healthy participants. CONCLUSIONS Aldosterone concentrations reported by the Adaltis and DSL nonextraction RIAs were consistently higher than those produced by the Nichols CLIA and the in-house RIA. The convenient Nichols CLIA showed better agreement with the in-house RIA, but the concentrations in healthy participants were frequently undetectable by this method. Uncritical application of cutoff values from the literature must be avoided.

[1]  张炜,et al.  Primary Aldosteronism , 2014, Springer New York.

[2]  O. Vonend,et al.  [Normokalemic primary hyperaldosteronism]. , 2006, Deutsche medizinische Wochenschrift.

[3]  F. Beuschlein,et al.  Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. , 2006, European journal of endocrinology.

[4]  R. Gordon,et al.  Plasma renin and aldosterone measurements in low renin hypertensive states , 2005, Trends in Endocrinology & Metabolism.

[5]  M. Boscaro,et al.  Diagnosis of primary aldosteronism: from screening to subtype differentiation , 2005, Trends in Endocrinology & Metabolism.

[6]  C. Maser-Gluth,et al.  Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. , 2004, Clinical chemistry.

[7]  J. Nicod,et al.  Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism , 2004, Journal of hypertension.

[8]  J. Hensen,et al.  Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. , 2002, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[9]  E. Boerwinkle,et al.  Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. , 2001, Mayo Clinic proceedings.

[10]  N. Lawson,et al.  Aldosterone and renin measurements , 2000, Annals of clinical biochemistry.

[11]  C. Gomez-Sanchez,et al.  Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. , 2000, The Journal of clinical endocrinology and metabolism.

[12]  D. Altman,et al.  Measuring agreement in method comparison studies , 1999, Statistical methods in medical research.

[13]  G. Sagnella,et al.  Extraction method and nonextracted kit method compared for measuring plasma aldosterone. , 1997, Clinical chemistry.

[14]  T. Stabler,et al.  Chemiluminescence immunoassay of aldosterone in serum. , 1991, Clinical chemistry.

[15]  T. Mckenna,et al.  Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. , 1991, The Journal of clinical endocrinology and metabolism.

[16]  C. E. Kater,et al.  Reassessment of the predictive value of the postural stimulation test in primary aldosteronism. , 1991, American journal of hypertension.

[17]  R. Gordon,et al.  IS ALDOSTERONE/RENIN RATIO USEFUL TO SCREEN A HYPERTENSIVE POPULATION FOR PRIMARY ALDOSTERONISM? , 1985, Clinical and experimental pharmacology & physiology.

[18]  W. Vetter,et al.  Highly sensitive microassay for aldosterone in unextracted plasma: comparison with two other methods. , 1984, The Journal of laboratory and clinical medicine.

[19]  C. Gomez-Sanchez,et al.  Further evaluation of saline infusion for the diagnosis of primary aldosteronism. , 1984, Hypertension.

[20]  D. Haack,et al.  Aldosterone metabolites and possible aldosterone precursors in hypertension. , 1983, Journal of steroid biochemistry.

[21]  C. Migeon,et al.  Measurement of plasma aldosterone by radioimmunoassay. , 1970, The Journal of clinical endocrinology and metabolism.

[22]  D. Seligson,et al.  Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.

[23]  F. Mantero,et al.  Does dynamic testing have a place in the modern assessment of endocrine hypertension? , 2003, Journal of endocrinological investigation.

[24]  A. Lenzi,et al.  Functional anatomy of the human vagina. , 2003, Journal of endocrinological investigation.

[25]  J. Buster,et al.  Chromatographic Separation of Steroid Hormones for Use in Radioimmunoassay , 1972 .

[26]  T. Kollevold,et al.  [Primary aldosteronism]. , 1969, Nordisk medicin.